June 20, 1:00 pm – 5:00 pm 
Presented by Mirixa 

The MTM Workshop seeks to go beyond the traditional scope of MTM discussions to highlight the hidden value these programs represent for both clinical and business strategy. Sessions will include expert panels and thought-leaders outlining the influence of MTM on medication adherence, condition-specific targeting, benefit-design strategy, and many other key managed care issues. 

The workshop will inform attendees about modern MTM strategies and delineate the different roles and opportunities for the various stakeholders within the health care industry. Additionally, this workshop will serve as a forum for health plans, pharmaceutical companies, and business leaders to share best practices with respect to managing chronic disease. Moreover, these strategies should include a multi-faceted approach to the issue including behavior and lifestyle management.  

Target Audience
The ideal target level for this workshop includes:

  • C-Suite Executives
  • Senior Staff including Vice Presidents, Managed Markets Executives, Product and Plan Design Professionals, and Account Managers
  • Clinical specialists including Medical Program Managers

We also encourage other stakeholders from the employer community, business coalitions and benefit consultants to engage in this valuable workshop.

Registration Rates
Members: $125
Non-members: $150


12:00 pm – 1:00 pmRefreshments and Networking Opportunity 
1:00 pm  – 1:15pmWelcome and Introduction
Finding Hidden Value in MTM

Initially, MTM was viewed as a means to “check the box” with CMS and comply with regulations. Health plans quickly realized, however, that MTM, and the host of pharmacist-delivered services that grew out of it, were generating positive ROI for the plan, better health for the patient, and engaging an underutilized and highly skilled clinical resource - the pharmacist. It became apparent that the combination of clinical vision, technology and community pharmacy were capable of resolving medication-related issues that had previously been resistant to other interventions. Learn why health plans are now incorporating targeted pharmacist-delivered services into populations beyond Medicare. 

Rick Solano, President and CEO, Mirixa Corporation 
1:15 pm – 2:45 pm General Session 
Applying Concepts to Case Studies 

Hear how a health plan has implemented MTM into its clinical and financial business strategy and the effect on member satisfaction. Disease-specific targeting for risk triage and value-based benefit implementation will be discussed, along with the impact of MTM components in comparative effectiveness research. You will also hear about an integrated pharmacy-based program aimed at creating positive, sustained medication related behavior change not realized with other methods. 

Bill Grambley, Senior Director, Pharmacy Advisor, Medicare and Medicaid Product Management, CVS Caremark 
2:45 pm – 3:00 pm  Break   
3:00 pm – 3:55 pmGeneral Session
Comprehensive Medication Management in Coordinated Care: 
Making the Case for Health Plans and Employers 

Health plans and employers benefit significantly when they provide reimbursement for medications that are safe, appropriate and effective for the patient. Pharmaceutical companies benefit when medications are appropriately utilized, resulting in clinical improvement and reductions in overall healthcare costs. This session will highlight the road to adoption and reimbursement for these services by health plans and employers, and will address potential barriers to—and opportunities for—program expansion.

Moderator: Terry McInnis, MD, MPH, President, Blue Thorn, Inc., and Co-Lead, Medication Management Task-Force, The Patient-Centered Primary Care Collaborative 
Amanda Brummel, PharmD, Director of Clinical Pharmacy Services, Fairview Health System 
Donna Altenpohl, Vice President, Public Policy, GlaxoSmithKline 
3:55 pm – 4:05 pmBreak 
4:05 pm  – 5:00 pmGeneral Session
Future Directions and Opportunities for MTM

MTM service delivery has yielded unanticipated benefits. Our panel will discuss the potential roles for pharmacist-delivered services as part of new care delivery models and population health management.

Terry McInnis
, MD, MPH, President, Blue Thorn, Inc., and Co-Lead, Medication Management Task-Force, The Patient-Centered Primary Care Collaborative 
Kim Swiger, RPh, Vice President, Clinical Products, Mirixa Corporation 
Rick Solano, President and CEO, Mirixa Corporation 


Speakers Include: 

Donna Altenpohl 

Donna Altenpohl is Vice President of Public Policy for GlaxoSmithKline. She joined GSK in 2006 as an Executive Account Manager for the Employer Segment. In 2008, she was promoted to Account Vice President of the Center for Medicare and Medicaid Services Team, which was enlarged to include HHS in 2009. Prior to working for GSK, Donna spent 16 years at Cigna HealthCare, where she held a series of management level positions in marketing, sales, product development and strategic planning. She holds a Bachelor of Arts degree from Colby College and is a graduate of the Transformational Leadership for Executives program, a GSK-sponsored developmental program at the Wharton School of Business at the University of Pennsylvania.

Amanda Brummel, PharmD 

Amanda Brummel has been working in Medication Therapy Management (MTM) for the past 12 years. She is Director of Clinical Pharmacy Services for Fairview Health System, a not-for-profit, integrated healthcare network. She has been the clinical supervisor for the MTM department, the MTM Operations & Program Manager, and in 2010, became the Director of Clinical Ambulatory Pharmacy Services. In this position, she works closely with the medical group to ensure pharmacy integration and is responsible for the development and oversight of the MTM program, as well as retail clinical services development. The MTM department includes 24 MTM practitioners in 27 different locations. She has helped to develop and implement multiple MTM employer programs and has worked with multiple payer groups to receive payment for MTM services. She is also an adjunct faculty member of the University of Minnesota. She teaches the elective course, How to Build an MTM Practice. She also co-developed an on-line Continuing Education course on building an MTM practice. 

Bill Grambley 

Bill Grambley runs CVS Caremark’s programs focused on supporting adherence and ensuring members are on all appropriate medications; in addition, he is responsible for products focused on supporting our Medicare and Medicaid clients. Recently, he lead the evolution of the award-winning Pharmacy Advisor Counseling program, an innovative solution focused on creating positive, sustained medication-related behavior change to assist our clients in managing total healthcare costs for their populations. He has been involved in developing key synergistic offerings for the combined retailer and PBM, including Maintenance ChoiceTM and, now, Pharmacy Advisor. He is currently developing the next generation of strategies to further drive positive member behavior change and lower total healthcare costs for CVS Caremark clients.

Terry McInnis, MD, MPH, FACOEM
Dr. Terry McInnis is President and Founder of Blue Thorn Inc. healthcare consultancy. She co-chairs The Center for Public Payer Implementation and co-leads the Medication Management Taskforce for the Patient-Centered Primary Care Collaborative. Dr. McInnis previously served as the Medical Director for Health Policy and Advocacy in the U.S. for GlaxoSmithKline (GSK). She has over 20 years of senior executive and clinical experience in various employer, military (United States Air Force Flight Surgeon), and hospital/group practice health management segments. Prior to joining GSK, she was the Corporate Medical Director for Michelin North America. She graduated from Erskine College with a BS (summa cum laude), and received her Doctor of Medicine degree from Wake Forest Medical School being designated a NIH student clinical scholar. She is Board Certified in Preventive and Occupational Medicine, a Fellow of the American College of Occupational and Environmental Medicine, and a Former Course Advisor to the Department of Continuing Education of Harvard University. 

Rick Solano 

Rick Solano is President & Chief Executive Officer of Mirixa Corporation. He has worked in health care for more than 26 years, providing software, services and solutions to providers, health plans and pharmaceutical manufacturers. He most recently served in executive positions at Emdeon and Cegedim-Dendrite, providing business leadership for new business ventures as well as mature large-scale organizations. He serves on the Board of Directors of Health 1st America's Charities. He holds an MBA degree from California Lutheran University and a BA from University of California.

Kim Swiger, RPh 

Kim Swiger is a registered pharmacist and is responsible for strategically guiding Mirixa’s product and service offerings, and clinical program design to correspond with market and industry trends. Kim brings more than 20 years of community pharmacy practice to her role. Prior to joining Mirixa, she spent the majority of her career at Ukrop’s Pharmacy where she was involved in innovative patient care programs, continuous quality improvement and pharmacy operations, including two APhA Foundation Projects. She is a committee chairperson with PQA, and is a member of APhA, Virginia Pharmacists Association, Georgia Pharmacists Association and the Academy of Managed Care Pharmacists. She earned her BS in Pharmacy from Virginia Commonwealth University School of Pharmacy.